Provided by Tiger Trade Technology Pte. Ltd.

SKB BIO

528.500
0.000
Volume:303.90K
Turnover:160.36M
Market Cap:126.31B
PE:-274.22
High:537.500
Open:519.000
Low:519.000
Close:528.500
52wk High:581.000
52wk Low:339.600
Shares:239.00M
HK Float Shares:177.00M
Volume Ratio:0.51
T/O Rate:0.17%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.927
ROE:-9.34%
ROA:-5.11%
PB:22.31
PE(LYR):-274.22
PS:52.77

Loading ...

Innovative Drug Stocks Surge Following Inclusion in National Essential Medicines List, Accelerating Grassroots Access

Stock News
·
Jul 15

Movement Alert|Kelun-Biotech Rises 10.8% in Regular Trading, Core TROP2 ADC Achieves Phase III Primary Endpoint in PD-L1 Negative NSCLC

Market Focus
·
Jul 15

Sichuan Kelun-biotech Biopharma Says Primary Endpoint Met for Phase 3 Study of Lung Cancer Treatment

Reuters
·
Jul 15

SKB BIO's Pivotal Drug Candidate Achieves Primary Endpoint in Phase 3 Lung Cancer Trial

Stock News
·
Jul 15

Kelun-Biotech’s sac-TMT + Keytruda Clears Phase 3 PFS Hurdle in First-Line PD-L1-Negative NSCLC

Bulletin Express
·
Jul 15

Kelun-biotech Says Phase 3 Sac-tmt Plus Keytruda Meets PFS Endpoint in First-line Pd-l1-negative NSCLC

Reuters
·
Jul 15

Sichuan Kelun-biotech Biopharmaceutical - Primary Endpoint Met for Phase 3 Study of Trop2 ADC Sacituzumab Tirumotecan with Pembrolizumab

THOMSON REUTERS
·
Jul 15

GLMS SEC: Significant Room for Improvement in First-Line Advanced Lung Cancer Treatment; Focus on SKB BIO's Global R&D Progress for sac-TMT

Stock News
·
Jul 14

Movement Alert|Kelun-Biotech Declines 3.17% in Regular Trading, Post-Placement Technical Pullback Continues

Market Focus
·
Jul 14

Movement Alert|Kelun-Biotech Biopharmaceutical Intraday Decline 3.1%, Technical Pullback Following Completion of HK$2.72 Billion Share Placement

Market Focus
·
Jul 13

SKB BIO Releases Updated Articles of Association Following Hong Kong H-Share Listing

Bulletin Express
·
Jul 10

SKB BIO Completes HK$2.72 Billion H-Share Placement; Core Shareholder’s Stake Eases to 62.53%

Bulletin Express
·
Jul 10

SKB BIO Completes HKD 2.75 Billion H-Share Placement, Expanding Issued Capital by 3.41%

Bulletin Express
·
Jul 10

Kelun-biotech Files HKEX Next-day Disclosure Return, Share Capital Rises on 5,838,000 New H Shares Placing

Reuters
·
Jul 10

Kelun-biotech Completes Hk$2.72 Billion H-share Placement at Hk$470.2 Per Share

Reuters
·
Jul 10

Biotech Stocks Surge as New National Essential Drug List Includes Innovative Therapies

Stock News
·
Jul 10

Sichuan Kelun-Biotech Seeks HK$2.7 Billion via Share Placement

MT Newswires Live
·
Jul 08

SKB BIO Announces Share Placement at Discount, Aiming to Raise Approximately HK$2.72 Billion

Stock News
·
Jul 08

Sichuan Kelun-biotech Prices 5,838,000-share H-share Placement at HK$ 470.2

Reuters
·
Jul 08

Sichuan Kelun-biotech Biopharmaceutical - to Place 5.84 Mln New H Shares at Hk$470.2 Per Share

THOMSON REUTERS
·
Jul 08